Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Sales | 2,215 | 1,490 | 2,081 | 1,684 | 1,171 |
| Cost of Goods | 1,778 | 1,363 | 1,586 | 1,362 | 1,115 |
| Gross Profit | 437 | 127 | 495 | 322 | 56 |
| Operating Expenses | 1,428 | 1,537 | 1,282 | 1,434 | 1,577 |
| Operating Income | -991 | -1,410 | -787 | -1,112 | -1,521 |
| Interest Expense | 211 | 229 | 76 | 45 | 0 |
| Other Income | 26 | 24 | 1 | 49 | 126 |
| Pre-tax Income | -1,176 | -1,615 | -862 | -1,108 | -1,395 |
| Net Income Continuous | -1,176 | -1,615 | -862 | -1,108 | -1,395 |
| Net Income | $-1,176 | $-1,615 | $-862 | $-1,108 | $-1,395 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 |
| EBITDA(a) | $-851 | $-1,283 | $-682 | $-960 | $-1,311 |